Page last updated: 2024-08-16

tibolone and Adverse Drug Event

tibolone has been researched along with Adverse Drug Event in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Jacobsen, DE; Melis, RJ; Olde Rikkert, MG; Verhaar, HJ	1
Helmond, FA; Landgren, BM; Langer, RD; Rymer, J	1

Trials

2 trial(s) available for tibolone and Adverse Drug Event

Article	Year
Raloxifene and tibolone in elderly women: a randomized, double-blind, double-dummy, placebo-controlled trial. Journal of the American Medical Directors Association, 2012, Volume: 13, Issue:2 Topics: Absorptiometry, Photon; Academic Medical Centers; Age Factors; Aged; Aged, 80 and over; Body Mass Index; Bone Density; Bone Density Conservation Agents; Confidence Intervals; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug-Related Side Effects and Adverse Reactions; Estrogen Receptor Modulators; Female; Follow-Up Studies; Humans; Middle Aged; Netherlands; Norpregnenes; Osteoporosis, Postmenopausal; Patient Safety; Raloxifene Hydrochloride; Reference Values; Risk Assessment; Severity of Illness Index; Treatment Outcome	2012
Effects of tibolone and continuous combined conjugated equine estrogen/medroxyprogesterone acetate on the endometrium and vaginal bleeding: results of the OPAL study. American journal of obstetrics and gynecology, 2006, Volume: 195, Issue:5 Topics: Aged; Biopsy; Contraceptive Agents, Female; Double-Blind Method; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Endometrium; Estrogen Receptor Modulators; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Osteoporosis; Ultrasonography; Uterine Hemorrhage	2006

Article

Year

Raloxifene and tibolone in elderly women: a randomized, double-blind, double-dummy, placebo-controlled trial.

Journal of the American Medical Directors Association, 2012, Volume: 13, Issue:2

Topics: Absorptiometry, Photon; Academic Medical Centers; Age Factors; Aged; Aged, 80 and over; Body Mass Index; Bone Density; Bone Density Conservation Agents; Confidence Intervals; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug-Related Side Effects and Adverse Reactions; Estrogen Receptor Modulators; Female; Follow-Up Studies; Humans; Middle Aged; Netherlands; Norpregnenes; Osteoporosis, Postmenopausal; Patient Safety; Raloxifene Hydrochloride; Reference Values; Risk Assessment; Severity of Illness Index; Treatment Outcome

2012

Effects of tibolone and continuous combined conjugated equine estrogen/medroxyprogesterone acetate on the endometrium and vaginal bleeding: results of the OPAL study.

American journal of obstetrics and gynecology, 2006, Volume: 195, Issue:5

Topics: Aged; Biopsy; Contraceptive Agents, Female; Double-Blind Method; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Endometrium; Estrogen Receptor Modulators; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Osteoporosis; Ultrasonography; Uterine Hemorrhage

2006